Delivery Order SPE2DB22D1103-SPE2DB23FE5GL

Award Date 8/8/23
Potential Completion Date 8/9/23
Potential Value $540
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,473.44 to Amerisourcebergen Drug Corporation for the supply of 4561889616 RESTASIS 0.05% eye emulsion in 60 single-use containers. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company, Amerisourcebergen Corporation. Performance will take place in Conshohocken, Pennsylvania over a one-day period from August 21 to August 22, 2023. The...
The Defense Logistics Agency awarded a $16,586 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 60 units of the ophthalmic solution to support DLA programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract spanning August 18 through 21, 2023. No subcontractors or set aside designations were identified. DLA manages the global supply...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $1,800.80 to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% RESTASIS eye emulsion. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility from August 22 to August 23, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a specific eye medication supports DLA's mission to provide logistics support for...
The Defense Logistics Agency awarded a $4,321 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 60 units of the product to the DLA under a firm fixed price contract. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period from July 7-10, 2023. No subcontractors or set aside designations were identified. The DLA manages the global supply chain for...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $16,306 to Amerisourcebergen Drug Corporation to supply RESTASIS 0.05% eye emulsion. The single delivery order is for 60 units of the product and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 6, 2023 under the Prime Vendor Program indefinite delivery/indefinite quantity contract. No subcontractors or set aside designations were identified. The Defense...
The Defense Logistics Agency awarded a $2,332.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% RESTASIS eye emulsion. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is September 28 through 29, 2023. As a top pharmaceutical distributor, Amerisourcebergen will fulfill this order to support the DLA's medical supply needs under its Prime Vendor Next contract vehicle. No...
The Defense Logistics Agency awarded a $3,988 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will deliver 30 units of the prescribed ophthalmic solution to a facility in Conshohocken, Pennsylvania by July 27, 2023 under the terms of the order. The parent company, Amerisourcebergen Corporation, will perform the contract through its corporate office division. No subcontractors or set aside...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $47,000 to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The single award was issued under an existing Prime Vendor contract vehicle to supply sixty units of the ophthalmic solution to a facility located in Conshohocken, Pennsylvania. Performance will be completed by September 14, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency...
The Defense Logistics Agency Troop Support Medical awarded a $6,549.08 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The contract calls for Amerisourcebergen to deliver 60 units of the eye emulsion to a location in Conshohocken, Pennsylvania by July 18, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order from Amerisourcebergen supports the Defense Logistics Agency's...
The Defense Logistics Agency awarded a $7,368.09 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 units of 0.05% RESTASIS eye emulsion. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is scheduled to be completed between July 27-28, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for eye medication supports the DLA's mission to provide logistics...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB23FE5GL
    Delivery Order

The Defense Logistics Agency awarded a $540 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 30 units of the prescribed ophthalmic solution to fulfill requirements under the contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. The order was issued against DLA's prime vendor pharmaceuticals contract vehicle and no subcontractors or set aside designations were specified. The RESTASIS product supports DLA's mission to provide quality healthcare supplies to military treatment facilities worldwide.

Generated 12/20/23, 11:14 AM